Demographics (3)
- AGE - Subject age at enrollment (phv00495503.v1.p1)
- SEX - Self-reported sex (phv00495502.v1.p1)
- SEX - Biological sex (phv00495497.v1.p1)
Geography (1)
- SITE - Site (phv00495501.v1.p1)
Other (16)
- CONSENT - Consent group (phv00495496.v1.p1)
- GENOTYPING/SEQUENCING_CENTER - Name of the center which conducted genotyping (phv00495514.v1.p1)
- mal.atp.3 - Binary outcome, positive smear result through 3 months follow up (phv00495509.v1.p1)
- mal.dvax - Malaria during vaccination period (phv00495507.v1.p1)
- mal.dvax.tot - Total number of malaria episodes during vaccination period (phv00495508.v1.p1)
- mal.vax1 - Malaria at time of first vaccination (phv00495506.v1.p1)
- MONTH - Month of Vaccination (phv00495504.v1.p1)
- SAMPLE_ID - Sample ID (phv00495511.v1.p1)
- SAMPLE_ID - Sample ID (phv00495499.v1.p1)
- SAMPLE_TYPE - Analyte Type (phv00495512.v1.p1)
- SUBJECT_ID - Subject ID (phv00495500.v1.p1)
- SUBJECT_ID - Subject id (phv00495495.v1.p1)
- SUBJECT_ID - Subject ID (phv00495498.v1.p1)
- TIMEPOINT - Timepoint (phv00495513.v1.p1)
- TREAT - Treatment arm (phv00495505.v1.p1)
- tte.mal.atp.6 - Time to smear positive event for malaria through 6 months follow up (phv00495510.v1.p1)